Ticker name:CTOR CITIUS ONCOLOGY, INC.

Country: US-Sector: Healthcare, Industry: Drug Manufacturers - General

Citius Oncology, Inc. focuses on the development of novel targeted oncology therapies. It also engages in the development of LYMPHIR, an orphan indication for the treatment of adults with relapsed or refractory cutaneous T-cell lymphoma. The company is headquartered in New York, New York. Citius Oncology, Inc. operates as a subsidiary of Citius Pharmaceuticals, Inc.

Market Cap 77M

Last close 0.826$

Largest 17 companies In Drug Manufacturers - General

# PositionTickerCompany NameMarket CapLast PriceAction
1LLYELI LILLY & Co960B1018.87$
2AZNASTRAZENECA PLC581B187.46$
3JNJJOHNSON & JOHNSON552B229.32$
4ABBVAbbVie Inc.375B212.3$
5NVSNOVARTIS AG287B150.45$
6MRKMerck & Co., Inc.279B113$
7AMGNAMGEN INC179B331.57$
8GILDGILEAD SCIENCES, INC.162B130.69$
9PFEPFIZER INC147B25.79$
10BMYBRISTOL MYERS SQUIBB CO120B58.54$
11SNYSanofi109B44.67$
12BIIBBIOGEN INC.28B187.8$
13OGNOrganon & Co.3.5B13.46$
14CTORCITIUS ONCOLOGY, INC.77M0.826$
15SRXHSRx Health Solutions, Inc.69M0.1175$
16SCLXScilex Holding Co51M6.01$
17MIRAMIRA PHARMACEUTICALS, INC.41M0.9676$